Inactive Instrument

Insiders Tissue Therapies Limited Australian S.E.

Equities

AU000000TIS8

End-of-day quote Australian S.E. Other stock markets
- ^AUD	-

Mar. 25	Dominion Minerals Limited Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Certain Options of Dominion Minerals Limited are subject to a Lock-Up Agreement Ending on 9-OCT-2023.	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Dominion Minerals Limited Announces Management Resignation	21-10-31	CI
Dominion Minerals : Names New CFO	21-10-08	MT
Dominion Minerals Limited Appoints Stephen Kelly as Company Secretary	21-10-07	CI
Dominion Minerals Limited Appoints Stephen Kelly as Chief Financial Offer	21-10-07	CI
Factor Therapeutics Limited has Changed its Name to Dominion Minerals Limited	21-09-26	CI
Factor Therapeutics Limited Announces Board Changes	21-07-26	CI
Factor Therapeutics Limited Announces Board Changes	21-04-19	CI
Factor Therapeutics Limited Announces Management Changes	20-07-23	CI
Factor Therapeutics Names David Brookes as Non-Executive Director	19-04-10	CI
Factor Therapeutics Limited Approves Director Changes	19-03-26	CI
Factor Therapeutics Announces Management Changes	19-02-04	CI
Factor Therapeutics Limited Announces Tenure Completion of Rosalind Wilson as Chief Executive Officer	19-01-24	CI
Factor Therapeutics Limited Announces Retirement of Robert Ryan from its Board	18-12-11	CI
Factor Therapeutics Limited Announces Christian Behrenbruch Transitions to Non-Executive Director	17-05-21	CI
Factor Therapeutics Limited Announces Executive Changes, Effective June 19, 2017	17-05-21	CI
Factor Therapeutics Limited Appoints John Michailidis as a Non-Executive Director	17-02-13	CI
Factor Therapeutics Limited Appoints Melanie Farris AGIA as Company Secretary ,Effective September 29, 2016	16-09-28	CI
Factor Therapeutics Limited Appoints Robert Ryan as Non-Executive Director	16-09-13	CI
Factor Therapeutics Limited Forms Medical Advisory Board	16-08-02	CI
Tissue Therapies Limited Announces Cessation of Mel Bridges as Director	15-11-30	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Tissue Therapies Limited Australian S.E.

Equities

AU000000TIS8

Insiders

Filters